PubRank

Tomás Zima

Author PubWeight™ 29.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lower retinol levels as an independent predictor of mortality in long-term hemodialysis patients: a prospective observational cohort study. Am J Kidney Dis 2010 1.43
2 Soluble receptor for advanced glycation end products in patients with decreased renal function. Am J Kidney Dis 2006 1.31
3 Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Invest 2007 1.07
4 Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res 2005 1.05
5 Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients. Nephrol Dial Transplant 2007 1.03
6 A419C (E111A) polymorphism of the glyoxalase I gene and vascular complications in chronic hemodialysis patients. Ann N Y Acad Sci 2007 0.95
7 Biochemical oxidative stress-related markers in patients with obstructive sleep apnea. Med Sci Monit 2011 0.93
8 Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer. Clin Biochem 2010 0.90
9 Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med 2006 0.85
10 Soluble cytokine receptors in renal vasculitis and lupus nephritis. Med Sci Monit 2002 0.84
11 Glycoxidation and inflammation in chronic haemodialysis patients. Nephrol Dial Transplant 2003 0.83
12 No benefit of hemodiafiltration over hemodialysis in lowering elevated levels of asymmetric dimethylarginine in ESRD patients. Blood Purif 2006 0.83
13 Advanced glycation end-products in patients with chronic alcohol misuse. Alcohol Alcohol 2004 0.82
14 Soluble RAGE, diabetic nephropathy and genetic variability in the AGER gene. Arch Physiol Biochem 2008 0.81
15 Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis? Kidney Blood Press Res 2006 0.81
16 Oxidative stress and endothelium influenced by metformin in type 2 diabetes mellitus. Eur J Clin Pharmacol 2007 0.81
17 Pathobiochemistry of nephrotic syndrome. Adv Clin Chem 2003 0.80
18 Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study. J Perinat Med 2008 0.79
19 Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients. Kidney Int Suppl 2003 0.79
20 Antiphospholipid antibodies in patients with lupus nephritis. Ren Fail 2003 0.79
21 Soluble receptor for advanced glycation end products in physiological and pathological pregnancy. Clin Biochem 2009 0.79
22 Pregnancy-associated plasma protein A (PAPP-A) and preeclampsia. Adv Clin Chem 2014 0.78
23 Signal transduction in alcohol-related diseases. Alcohol Clin Exp Res 2005 0.78
24 RAGE polymorphisms, renal function and histological finding at 12 months after renal transplantation. Clin Biochem 2008 0.78
25 Pregnancy-associated plasma protein a and soluble receptor for advanced glycation end products after kidney transplantation. Kidney Blood Press Res 2007 0.78
26 Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes. Scand J Clin Lab Invest 2010 0.78
27 Resting energy expenditure and thermal balance during isothermic and thermoneutral haemodialysis--heat production does not explain increased body temperature during haemodialysis. Nephrol Dial Transplant 2007 0.78
28 Advanced glycation end products in hemodialyzed patients with diabetes mellitus correlate with leptin and leptin/body fat ratio. Ren Fail 2003 0.77
29 Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients. Kidney Blood Press Res 2010 0.77
30 Plasma calprotectin in chronically dialyzed end-stage renal disease patients. Inflamm Res 2009 0.77
31 Glyoxalase I Glu111Ala polymorphism in patients with breast cancer. Cancer Invest 2009 0.77
32 Concentrations of sRAGE in serum and follicular fluid in assisted reproductive cycles--a preliminary study. Clin Lab 2010 0.77
33 Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome. Med Sci Monit 2002 0.76
34 Effect of hemodiafiltration on pregnancy-associated plasma protein A (PAPP-A) and related parameters. Ren Fail 2006 0.75
35 [Pharmacogenetic aspects of current pharmacotherapy]. Cas Lek Cesk 2010 0.75
36 Determinants of circulating matrix metalloproteinase-2 and pregnancy-associated plasma protein-A in patients with chronic kidney disease. Clin Lab 2012 0.75
37 Advanced glycation end products and acute myocardial infarction. Med Princ Pract 2010 0.75
38 Recent progress in the pathogenesis of nephrotic proteinuria. Crit Rev Clin Lab Sci 2008 0.75